Instytut „Pomnik – Centrum Zdrowia Dziecka” – instytut naukowy i jednostka badawczo-rozwojowa Ministerstwa Zdrowia utworzony w 1977 w Warszawie z inicjatywy Ewy Szelburg-Zarembiny; prowadzi również działalność szpitalną, jest jednocześnie pomnikiem dzieci, ofiar II wojny światowej.

During the past decade, Instytut "Pomnik - Centrum Zdrowia Dziecka" conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 10 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 8 clinical trials were completed. i.e. 42.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instytut "Pomnik - Centrum Zdrowia Dziecka"" #1 sponsor was "Takeda" with 6 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Mirum Pharmaceuticals, Inc." with 4 trials sponsored, "Albireo" with 3 trials sponsored and "Guerbet" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut "Pomnik - Centrum Zdrowia Dziecka"" #1 collaborator was "Ovid Therapeutics Inc." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instytut "Pomnik - Centrum Zdrowia Dziecka"" are "Biliary Atresia" (3 trials), "Colitis, Ulcerative" (3 trials), "Crohn's Disease" (3 trials), "Muscular Atrophy, Spinal" (3 trials) and "Alagille Syndrome" (2 trials). Many other conditions were trialed in "Instytut "Pomnik - Centrum Zdrowia Dziecka"" in a lesser frequency.

Most popular intervention types in "Instytut "Pomnik - Centrum Zdrowia Dziecka"" are "Drug" (35 trials), "Biological" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Maralixibat" (4 trials), "Ustekinumab" (3 trials), "Apitegromab" (2 trials) and "Dexlansoprazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instytut "Pomnik - Centrum Zdrowia Dziecka"" are 41 trials for "All" genders.

Currently, there are 21 active trials in "Instytut "Pomnik - Centrum Zdrowia Dziecka"". 2 are not yet recruiting, 14 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Instytut "Pomnik - Centrum Zdrowia Dziecka", undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instytut "Pomnik - Centrum Zdrowia Dziecka", 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Instytut "Pomnik - Centrum Zdrowia Dziecka" has several departments that took part in Clinical trials: "The Children´s Memorial Istitute Warsaw" - 4 trials, "The Children's Memorial Health Institute Department of Neurology and Epileptology" - 4 trials, "Instytut Pomnik-Centrum Zdrowia Dziecka, Klinika Nefrologii, Transp. Nerek i Nadcisnienia Tetniczego" - 3 trials, "Department of Gastroenterology, Hepatology and Feeding Disorders" - 2 trials, "Instytut Pomnik Centrum Zdrowia Dziecka; Klinika Neurologii i Epileptologii" - 2 trials, "Instytut Pomnik-Centrum Zdrowia Dziecka; Klinika Onkologii" - 2 trials, "Department of Pediatric Nutrition and Metabolic Diseases; The Children's Memorial Health Institute" - 2 trials